Assignee
SHANGHAI RINGENE BIOPHARMA CO LTD
CN·3 granted patents·3 pending applications·0 citations·filing 2018–2021
Top patents by PatentIndex Score
6 records- 0151US12281118B2Nitrogen-containing fused heterocyclic SHP2 inhibitor compound, preparation method, and useSHANGHAI RINGENE BIOPHARMA CO LTD·Filed 2019·Granted Apr 22, 2025·0 cites·6 claims
- 0248US2024254117A1Pyrimido-heterocyclic compounds, and preparation method therefor and use thereofSHANGHAI RINGENE BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0345US2023312564A1Aromatic ring-lactam compound, preparation method therefor and use thereofSHANGHAI RINGENE BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0441US12459939B2Acylaminopyrrolo-pyridone compound, preparation method therefor and use thereofSHANGHAI RINGENE BIOPHARMA CO LTD·Filed 2020·Granted Nov 4, 2025·0 cites·14 claims
- 0541US11267815B2Class of amino-substituted nitrogen-containing fused ring compounds, preparation method therefor, and use thereofSHANGHAI RINGENE BIOPHARMA CO LTD·Filed 2018·Granted Mar 8, 2022·0 cites·17 claims
- 0641US2023174526A1Benzothiazolyl biaryl compound, and preparation method and useSHANGHAI RINGENE BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI RINGENE BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →